Assessing Your Patients for HCV and HIV
Why It Matters in OB/GYN Practice Today
Meeting Slides
HCV Clinical Practice Guidelines
HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C.
American Association for the Study of Liver Diseases/Infectious Diseases Society of America, 2017.
Testing Recommendations for Hepatitis C Virus Infection.
Centers for Disease Control and Prevention.
A Guide to Comprehensive Hepatitis C Counseling and Testing.
Centers for Disease Control and Prevention.
Hepatitis C in Pregnancy: Screening, Treatment, and Management.
Society for Maternal-Fetal Medicine.
Hepatitis B and Hepatitis C in Pregnancy.
The American College of Obstetricians and Gynecologists.
Viral Hepatitis Surveillance — United States, 2016.
Centers for Disease Control and Prevention, 2016.
HIV Clinical Practice Guidelines
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With HIV.
US Department of Health and Human Services, 2017 (last updated October 2018).
Guidelines for Managing Advanced HIV Disease and Rapid Initiation of Antiretroviral Therapy.
World Health Organization. Geneva, 2017.
Patients With HIV/HCV Coinfection.
American Association for the Study of Liver Diseases/Infectious Diseases Society of America, 2018 Update.
Preexposure Prophylaxis for the Prevention of HIV Infection in the United States—2017 Update.
Centers for Disease Control and Prevention/United States Public Health Service.
Provider Resource
Harm Reduction Coalition.
American Academy of HIV Medicine, 2018.
Patient Resources
HCV Patient Education Resources.
Centers for Disease Control and Prevention.
Fact Sheets for Patients.
Hepatitis C and Injection Drug Use.
This webpage provides concise information regarding HCV risk, transmission, and prevention in people who inject drugs.
HIV Patient Resources.
Centers for Disease Control and Prevention.
Resources for Persons Living With HIV.
Suggested Readings
Vertical transmission of hepatitis C: towards universal antenatal screening in the era of new direct acting antivirals (DAAs)? Short review and analysis of the situation in Switzerland.
Aebi-Popp K, et al. J Virus Erad. 2016;2(1):52-54.
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV. Karampatou A, et al. J Hepatol. 2018;68(1):33-41.
Karampatou A, et al. J Hepatol. 2018;68(1):33-41.
Medical and behavioral approaches to engage people who inject drugs into care for hepatitis C virus infection.
Gonzalez SA, et al. Addict Disord Their Treat. 2017;16(2 suppl 1):S1-S23.
National Viral Hepatitis Action Plan 2017–2020.
US Department of Health and Human Services, 2017.
The HCV care continuum does not end with cure: a call to arms for the prevention of reinfection.
Falade-Nwulia O, Sulkowski M. J Hepatol. 2017;66(2):267-269.
Treatment of HCV in persons who inject drugs: treatment as prevention.
Grebely J, Dore GJ. Clin Liver Dis. 2017;9(4):77-80.
Why It Matters in OB/GYN Practice Today
Relevant Resources
The PCPs Role in Preventing HIV
What Do You Know About PrEP?
Optimizing Use of Clinical Evidence & Pharmacoeconomic Models in Managed Care
Advances in the Diagnosis and Treatment of Nonalcoholic Steatohepatitis
What Do You Know About PrEP?
Got it? Treat it!
The Critical Role of the Community Pharmacist
Bringing Local Communities Together to Eliminate Coinfection Through Knowledge and Partnerships.
Volume 1: Rapid ART Initiation: A New Addition to the HIV-Care Tool Box
The Emerging Role of the Diabetologist
Key Issues Impacting OB/GYN Practice
An Interactive Experience Highlighting Recent Clinical Advances
Hot Topics in HBV, HCV, and NASH
Emerging Concepts in Patient Management
Building Your Understanding to Combat a Growing Problem
Volume II: Expanding Evidence for the Role of Rapid ART Initiation in HIV Practice
A Treater’s Guide to Optimizing Care in the Aging Patient with Comorbidities
How the Pharmacist Can Make a Difference
HIV Can Be Prevented— Are You Doing Your Part?
Rapid Start ART — A New Model for HIV Care
Understanding the Growing Syndemic — Opioids, HCV, and HIV
Appraising the Therapeutic Armamentarium in Moderate and Severe Disease
A PrEP Primer
The PCP’s Role in HCV Elimination
What the Pharmacist Needs to Know about PrEP
The Rapid ART Standard of Care: From Evidence to Healthcare Equity
Maximizing Your Role to Impact Patient Outcomes
Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV
Benefits, Barriers, & Best Practices in an Advancing Field
Practical Solutions Across the Spectrum of Care
A PEP/PrEP Training Guide for Pharmacists
An Interactive Learning Experience
A Focus on Clinical Evidence and Guideline Recommendations
A Critical Step Toward HCV Elimination
Considering the Patient, the Provider, and the Science
A Multidisciplinary Online Mini-Curriculum
Volume 1: A Guided Tour of the Evidence Driving Selection of First-line Advanced Therapies in Moderate to Severe IBD
Debates and Discussions about Monoclonal Antibody Therapies
An Update on Monoclonal Antibody Therapies
Establishing Clinical Readiness Through Mentored Learning
Interdisciplinary Strategies for Adult and Pediatric Patients
